Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Minoxidil and finasteride effectively treat hair loss.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

SHBG may be a useful early indicator and treatment target for PCOS.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Hair style affects perceptions of age, health, and attractiveness more than hair color does.